TickerFactsScreenerDevelopers

Outlook Therapeutics, Inc. (OTLK) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$15.51M2018: -$33.04M2019: -$32.29M2020: -$31.79M2021: -$54.25M2022: -$56.67M2023: -$42.97M2024: -$68.79M2025: -$51.83M-$51.83M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$51.83M+24.7%
2024-$68.79M-60.1%
2023-$42.97M+24.2%
2022-$56.67M-4.5%
2021-$54.25M-70.7%
2020-$31.79M+1.5%
2019-$32.29M+2.3%
2018-$33.04M-113.1%
2017-$15.51M—